Back to Screener

Healthcare

NeuroPace, Inc.(NPCE)

Live Price

Offline

$16.47

+0.67% today

Window Change

-5.50%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$580.00M
Revenue Growth
+25.1%
EPS Growth
+29.0%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

NeuroPace, Inc. (NPCE) is a Healthcare stock with a market cap of $580.00M and listed on NASDAQ. The stock last traded around $16.47 and down 5.5% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +25.1%, EPS growth of +29.0%, a dividend yield of 0.0%. What stands out right now is revenue +25.1%, EPS +29.0%, free cash flow +37.9% with operating margin -16.3% and ROIC -18.2%. Valuation sits in the middle of the pack at price/sales 5.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NPCE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NPCE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NPCE

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NPCE Max Drawdown

-9.19%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NPCE and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.19
โ€”
โ€”
Est 21647.6B
โ€”
May 12
โ€”
Mar 3, 26
โœ“
-0.08
Est -0.14
+42.9%
26588.0B
Est 24746.2B
+7.4%
Mar 3
โ€”
Nov 4, 25
โœ“
-0.11
Est -0.20
+45.0%
27354.0B
Est 25032.5B
+9.3%
Nov 4
โ€”
Aug 12, 25
โœ—
-0.26
Est -0.24
-8.3%
23520.0B
Est 24433.1B
-3.7%
Aug 12
โ€”
May 13, 25
โœ“
-0.21
Est -0.26
+19.2%
22524.0B
Est 22710.3B
-0.8%
May 13
โ€”
Mar 4, 25
โœ“
-0.18
Est -0.25
+28.0%
21466.0B
Est 21559.9B
-0.4%
Mar 4
โ€”
Nov 12, 24
โœ“
-0.19
Est -0.26
+26.9%
21060.0B
Est 20909.3B
+0.7%
Nov 12
โ€”
Aug 13, 24
โœ“
-0.26
Est -0.29
+10.3%
19256.0B
Est 18300.0B
+5.2%
Aug 13
โ€”
May 8, 24
โ€”
-0.32
Est -0.32
0.0%
18124.0B
Est 17300.0B
+4.8%
May 8
โ€”
Mar 5, 24
โœ“
-0.23
Est -0.33
+30.3%
18012.0B
Est 17460.0B
+3.2%
Mar 5
โ€”
Nov 6, 23
โœ“
-0.28
Est -0.39
+28.2%
16427.0B
Est 15790.0B
+4.0%
Nov 6
โ€”
Aug 8, 23
โœ“
-0.36
Est -0.47
+23.4%
16510.0B
Est 12620.0B
+30.8%
Aug 8
โ€”
May 4, 23
โœ“
-0.41
Est -0.46
+10.9%
14472.0B
Est 12170.0B
+18.9%
May 4
โ€”
Mar 2, 23
โœ“
-0.45
Est -0.49
+8.2%
12789.0B
Est 12170.0B
+5.1%
Mar 2
โ€”
Nov 8, 22
โœ“
-0.48
Est -0.52
+7.7%
11157.0B
Est 9900.0B
+12.7%
Nov 8
โ€”
Aug 11, 22
โœ—
-0.52
Est -0.44
-18.2%
10200.0B
Est 11079.9B
-7.9%
Aug 11
โ€”
May 12, 22
โœ—
-0.47
Est -0.46
-2.2%
11374.0B
Est 10644.3B
+6.9%
May 12
โ€”
Mar 10, 22
โœ—
-0.44
Est -0.33
-33.3%
10997.0B
Est 11000.0B
-0.0%
Mar 10
โ€”
Nov 10, 21
โœ—
-0.34
Est -0.30
-13.3%
10339.0B
Est 8960.5B
+15.4%
Nov 10
โ€”
Aug 12, 21
โœ“
-0.36
Est -0.39
+7.7%
12630.0B
Est 11300.0B
+11.8%
Aug 12
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar